Tirzepatide is a synthetic compound originally developed for the treatment of type 2 diabetes, and has also demonstrated protective effects on the cardiovascular system. It is derived from gastric inhibitory polypeptide (GIP) and uniquely combines its activity with that of glucagon-like peptide-1 (GLP-1). Thanks to this dual mechanism, Tirzepatide can help reduce blood sugar levels, improve insulin sensitivity, and enhance satiety — making it a promising agent in metabolic health management.